Dr. Ameet Dravid

MD (Medicine), HIVS

Consultant

Department of Infectious Diseases

Areas of Expertise:

●    HIV medicine
●    COVID-19
●    Tuberculosis
●    Tropical diseases like malaria, dengue, leptospirosis and rickettsial fever
●    Multi-drug resistant gram negative and gram-positive bacterial infections
●    Invasive fungal infections
 

Qualifications:

MBBS (2001)
BJ Medical College, Pune, Maharashtra

MD Medicine (2007)
Lokmanya Tilak Municipal Medical College, Sion, Mumbai, Maharashtra

American Academy Certified HIV Specialist (AAHIVS)
American Academy Of HIV Medicine, USA
 

Years of Experience:

13 years

Languages:

English, Marathi, Hindi

Awards and Achievements:

●    Scholarship to attend "Advanced course in HIV Medicine" which was held at Montpellier, France
●    Awarded scholarship to attend the “Research course in HIV Medicine” which was held at Zagreb, Croatia
●    Junior researcher award, ID week, San Diego, USA, 2012
●    EACS Scholarship to attend 15th European AIDS Conference held at Barcelona, Spain.
●    Member, Clinical Infectious Diseases Society (CIDS), India
●    Member, American academy of HIV Medicine (AAHIVM)
●    Member, AIDS society of India (ASI)
●    Member, International AIDS society (IAS)
●    Member, European AIDS Clinical society (EACS)

 

Publications:

●    Dravid A, Kashiva R, Khan Z, Bande B, Memon D, Kodre A, Mane M et al. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India. Mycoses. 2022 May;65(5):526-540. doi: 10.1111/myc.13435. Epub 2022 Mar 10. PMID: 35212032; PMCID: PMC9115310. 

●    Arora S, Hemmige VS, Mandke C, Chansoria M, Rawat SK, Dravid A et al. Mycotic Infections in COVID-19 (MUNCO) Network. Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021. Emerg Infect Dis. 2021;27(11):2963-2965. doi: 10.3201/eid2711.211322. Epub 2021 Sep 29. PMID: 34586056; PMCID: PMC8544967.

●     Dravid A, Kashiva R, Khan Z, Memon D, Kodre A, Potdar P, Mane D et al. Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India. Medicine (Baltimore). 2021 Jul 23;100(29):e26705. doi: 10.1097/MD.0000000000026705. PMID: 34398044; PMCID: PMC8294888. 

●    Dravid AN, Mane DN, Khan ZA. Neurological issues during severe COVID-19 in a tertiary level hospital in Western India. Neurosci Lett. 2021 Apr 1;749:135692. doi: 10.1016/j.neulet.2021.135692. Epub 2021 Feb 13. PMID: 33592305; PMCID: PMC7881741.

●    Dravid A, Natarajan K, Medisetty M, Gawali R, Mahajan U, Kulkarni M, et al. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect Dis. 2019 Aug 13;19(1):714. PubMed PMID: 31409289; PubMed Central PMCID: PMC6692924.

●    Natrajan K, Medisetty M, Gawali R, Tambolkar A, Patel D, Thorat V, Dubale N, Khirid V, Saraf C, Dravid A. Strongyloidosis Hyperinfection Syndrome in an HIV-Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome. Case Rep Infect Dis. 2018;2018:6870768. PubMed PMID: 30510823; PubMed Central PMCID: PMC6230409.

●    Dravid AN, Gawali R, Betha TP, Sharma AK, Medisetty M, Natrajan K et al. Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India. Medicine (Baltimore). 2020 Jun 12; 99 (24):e20516. doi: 10.1097/MD.0000000000020516. PMID: 32541474; PMCID: PMC7302684.

●    Dravid AN, Natrajan K, Kulkarni MM, Saraf CK, Mahajan US, Kore SD, et al. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India. Medicine (Baltimore). 2018 Feb; 97(8):e9969. PubMed PMID: 29465595; PubMed Central PMCID: PMC5841989.

●    Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, et al. Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. J Virus Erad. 2016 Oct 5;2(4):243-250. PubMed PMID: 27781109; PubMed Central PMCID: PMC5075354.

●    Dravid A, Betha TP, Sharma AK, Gawali R, Mahajan U, Kulkarni M et al. Efficacy and safety of a single-tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV-1-infected subjects on nonnucleoside reverse transcriptase inhibitor-containing first-line antiretroviral therapy in Pune, India. HIV Med. 2020 Oct; 21(9):578-587. doi: 10.1111/hiv.12912. Epub 2020 Jul 20. PMID: 33021066; PMCID: PMC7539943.
 

Research Papers:

  • Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome. - Click Here to Read
  • Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single center experience from Pune, Western India - Click Here to Read